Reported Reactions

Devices › Device types

FDA product code QJZ · class 2 · Cardiovascular

Extracorporeal system for long-term respiratory / cardiopulmonary failure: medical device reports filed with FDA

512 reports carry this product code, 2020–2026; 1 brands with a page.

512
reports with this product code
0% of all MAUDE reports
111
reports, 12 months to August 2026
130 in the 12 months before
86.5%
classified as malfunction
62.3% across all reports
5.5%
classified as death, as reported
0.9% across all reports

Product code QJZ is FDA's classification for "Extracorporeal system for long-term respiratory / cardiopulmonary failure" (cardiovascular panel), a class 2 device. 512 medical device reports carry this product code, 0% of the MAUDE database, from August 2020 to August 2026.

111 reports arrived in the 12 months to August 2026, down 15% from 130 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (86.5%), injury (8%) and death (5.5%). 1 brand name with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
XLUNG Kit 230308583.2%89.3%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01019Sep 2021: 4Oct 2021: 0Nov 2021: 11Dec 2021: 62022Jan 2022: 2Feb 2022: 9Mar 2022: 12Apr 2022: 7May 2022: 3Jun 2022: 5Jul 2022: 4Aug 2022: 2Sep 2022: 0Oct 2022: 3Nov 2022: 2Dec 2022: 42023Jan 2023: 1Feb 2023: 6Mar 2023: 14Apr 2023: 10May 2023: 10Jun 2023: 7Jul 2023: 17Aug 2023: 8Sep 2023: 8Oct 2023: 5Nov 2023: 8Dec 2023: 102024Jan 2024: 6Feb 2024: 10Mar 2024: 5Apr 2024: 7May 2024: 4Jun 2024: 4Jul 2024: 2Aug 2024: 7Sep 2024: 6Oct 2024: 6Nov 2024: 11Dec 2024: 72025Jan 2025: 19Feb 2025: 12Mar 2025: 7Apr 2025: 11May 2025: 13Jun 2025: 7Jul 2025: 16Aug 2025: 15Sep 2025: 9Oct 2025: 7Nov 2025: 5Dec 2025: 102026Jan 2026: 3Feb 2026: 16Mar 2026: 11Apr 2026: 6May 2026: 12Jun 2026: 17Jul 2026: 8Aug 2026: 7

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death5.5%28
Injury8%41
Malfunction86.5%443
Other0%0
Not given0%0

Who filed

Manufacturer report96.9%496
Voluntary report1.8%9
User facility report0%0
Distributor report1.4%7
Not given0%0

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Fluid/blood leak18435.9%
Insufficient device problem information10019.5%
Communication or transmission problemthe device could not communicate or transmit9017.6%
Output problem7715%
Incorrect, inadequate or imprecise result or readings7414.5%
Mechanical problema mechanical problem6713.1%
Leak/splashthe device leaked6512.7%
Protective measures problem132.5%
Device alarm system122.3%
Obstruction of flow122.3%
Infusion or flow problema problem with flow or infusion102%
Material integrity problema problem with the device material102%
Electrical /electronic property probleman electrical or electronic problem81.6%
Crackthe device cracked71.4%
Improper flow or infusion61.2%
Material separation61.2%
Noise, audible61.2%
Air/gas in device51%
Defective component40.8%
Display or visual feedback problem40.8%

Questions about extracorporeal system for long-term respiratory / cardiopulmonary failure reports

What is product code QJZ?

FDA's classification code for "Extracorporeal system for long-term respiratory / cardiopulmonary failure", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.

How many reports carry this code?

512 reports through August 2026, 111 of them in the latest 12 months.

Which brands appear most often?

XLUNG Kit 230 (308). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.